AIToday
AI in HealthcareTop Companies' AI MovesAI Business & IndustryTop Companies AIPublished: Oct 9, 2026, 06:31 JST

BioInvestGPT AI predicted Derdelsiran trial failure

BioInvestGPT AI predicted Derdelsiran trial failure

3 Key Points

  1. What happened

    BioInvestGPT's July simulation of Derdelsiran predicted no significant efficacy in late-stage trials; Novartis's stock fell 11% and $30 billion in market value was erased.

  2. Why it matters

    So far 5 of BioInvestGPT's 6 predictions have been correct, suggesting AI simulations may help pharma partners screen which drug programs to advance or value as acquisition targets.

WHO IT HITSPharma R&D and business-development teams evaluating which drug programs to fund, partner on, or acquire are the most direct audience, since the body says AI simulations are already used to spot programs worth advancing and to value acquisition targets.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

FAQ
How accurate has BioInvestGPT's AI been so far?
The body says that of 6 clinical-trial outcome predictions it detailed to Reuters, 5 have been correct so far.
Where did BioInvestGPT miss?
It forecast good results for Novartis's Pelacarsen, but Novartis said in September that the late-stage trial did not reduce the risk of serious heart attack or stroke in patients with genetic risk factors.
Top Companies AIRead Original Article

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleKansai Electric starts Japan's first nuclear PPAs as AI-driven data centers strain grid